Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Tempest Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 13 | −3 |
| Shares | 3.08M | 3.07M | −13.6K (−0.4%) |
| Value | $5.36M | $3.54M | −$1.82M (−34.0%) |
New holders (0)
Institutions that held Tempest Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (3)
Institutions that held Tempest Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Millennium Management LLC | 10,964 | $19.0K |
| UBS Group AG | 2,869 | $5.00K |
| BNP Paribas Arbitrage, SA | 73 | $127 |